The Global Epidemiology of Diabetes and Kidney Disease

Overview

Journal Adv Chronic Kidney Dis

Specialty Nephrology

Date 2018 Mar 28

PMID 29580576

Citations 235

Authors

Digsu N Koye

Dianna J Magliano

Robert G Nelson

Meda E Pavkov

Affiliations

Soon will be listed here.

Abstract

The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in low- and middle-income countries. In most developed countries, type 2 diabetes is presently the leading cause of end-stage renal disease and also contributes substantially to cardiovascular disease. In countries with weaker economies type 2 diabetes is rapidly replacing communicable diseases as a leading cause of kidney disease and is increasingly competing for scarce health care resources. Here, we present a narrative review of the prevalence and incidence of diabetes-related kidney disease worldwide. Mortality among those with diabetes and kidney disease will also be explored. Given the high morbidity and mortality associated with chronic kidney disease, we will also examine the level of awareness of this disease among people who have it.

Citing Articles

Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications.

Julian M, Codina P, Lupon J, Zamora E, Perez-Montes de Oca A, Domingo M Cardiovasc Diabetol. 2025; 24(1):104.

PMID: 40045364 PMC: 11884049. DOI: 10.1186/s12933-025-02632-9.

Global, regional, and national burden of chronic kidney disease due to diabetes mellitus type 2 from 1990 to 2021, with projections to 2036: a systematic analysis for the Global Burden of Disease Study 2021.

Hu R, Zhao Z, Xie L, Ma Z, Wu W, Li S Front Med (Lausanne). 2025; 12:1531811.

PMID: 40034386 PMC: 11872908. DOI: 10.3389/fmed.2025.1531811.

The role of endothelin receptor antagonists in kidney disease.

Ma X, Liang Y, Chen W, Zheng L, Lin H, Zhou T Ren Fail. 2025; 47(1):2465810.

PMID: 40015728 PMC: 11869344. DOI: 10.1080/0886022X.2025.2465810.

Urinary Fetuin-A with Specific Post-Translational Modification in Type 1 Diabetes Patients with Normoalbuminuria and Preserved Kidney Function.

Bozicevic S, Bulum T, Smircic Duvnjak L, Vucic Lovrencic M Diagnostics (Basel). 2025; 15(4).

PMID: 40002573 PMC: 11854771. DOI: 10.3390/diagnostics15040423.

Association of Kidney Function With 10-Year Risk of Atherosclerotic Cardiovascular Disease, Cardiovascular Disease and Its Risk Factors Among Women With Type 2 Diabetes Mellitus.

Siddiqui K, George T, Mujammami M, Alfadda A, Nawaz S, Rafiullah M Int J Womens Health. 2025; 17:449-457.

PMID: 39990930 PMC: 11846610. DOI: 10.2147/IJWH.S485470.

References

Kramer H, Nguyen Q, Curhan G, Hsu C . Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003; 289(24):3273-7. DOI: 10.1001/jama.289.24.3273. View

Parving H, Lewis J, Ravid M, Remuzzi G, Hunsicker L . Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006; 69(11):2057-63. DOI: 10.1038/sj.ki.5000377. View

Hemmelgarn B, Manns B, Lloyd A, James M, Klarenbach S, Quinn R . Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010; 303(5):423-9. DOI: 10.1001/jama.2010.39. View

Minges K, Zimmet P, Magliano D, Dunstan D, Brown A, Shaw J . Diabetes prevalence and determinants in Indigenous Australian populations: A systematic review. Diabetes Res Clin Pract. 2011; 93(2):139-149. DOI: 10.1016/j.diabres.2011.06.012. View

Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo N . Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int. 2006; 70(4):800-6. DOI: 10.1038/sj.ki.5001641. View

Bruck K, Stel V, Gambaro G, Hallan S, Volzke H, Arnlov J . CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2015; 27(7):2135-47. PMC: 4926978. DOI: 10.1681/ASN.2015050542. View

Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9):829-841. PMC: 4109980. DOI: 10.1056/NEJMoa1008862. View

Thomas M, MacIsaac R, Jerums G, Weekes A, Moran J, Shaw J . Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care. 2009; 32(8):1497-502. PMC: 2713618. DOI: 10.2337/dc08-2186. View

Atkinson M, Eisenbarth G, Michels A . Type 1 diabetes. Lancet. 2013; 383(9911):69-82. PMC: 4380133. DOI: 10.1016/S0140-6736(13)60591-7. View

10.

Laranjinha I, Matias P, Mateus S, Aguiar F, Pereira P, Perneta Santos M . Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?. Nefrologia. 2016; 36(5):503-509. DOI: 10.1016/j.nefro.2016.03.025. View

11.

Lu B, Song X, Dong X, Yang Y, Zhang Z, Wen J . High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complications. 2008; 22(2):96-103. DOI: 10.1016/j.jdiacomp.2007.08.001. View

12.

Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M . Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006; 17(7):2034-47. DOI: 10.1681/ASN.2005101085. View

13.

Sarnak M, Levey A, Schoolwerth A, Coresh J, Culleton B, Hamm L . Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and.... Hypertension. 2003; 42(5):1050-65. DOI: 10.1161/01.HYP.0000102971.85504.7c. View

14.

Zimmet P, Magliano D, Herman W, Shaw J . Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014; 2(1):56-64. DOI: 10.1016/S2213-8587(13)70112-8. View

15.

Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N . Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003; 26(4):1258-64. DOI: 10.2337/diacare.26.4.1258. View

16.

Geiss L, Wang J, Cheng Y, Thompson T, Barker L, Li Y . Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014; 312(12):1218-26. DOI: 10.1001/jama.2014.11494. View

17.

Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A . Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016; 4(5):e307-19. DOI: 10.1016/S2214-109X(16)00071-1. View

18.

Viswanathan V, Tilak P, Kumpatla S . Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res. 2012; 136(1):46-53. PMC: 3461717. View

19.

Wakasugi M, Kazama J, Narita I, Iseki K, Fujimoto S, Moriyama T . Association between Overall Lifestyle Changes and the Incidence of Proteinuria: A Population-based, Cohort Study. Intern Med. 2017; 56(12):1475-1484. PMC: 5505901. DOI: 10.2169/internalmedicine.56.8006. View

20.

Bailey R, Wang Y, Zhu V, Rupnow M . Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes. 2014; 7:415. PMC: 4091951. DOI: 10.1186/1756-0500-7-415. View